Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Harvoni

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Harvoni was produced by Bristol-Myers Squibb.

Novartis knocks Pfizer off sales leader board

Novartis knocks Pfizer off sales leader board In fact Gilead's total sales grew from £10.8bn in 2013 to $24.4bn in 2014 and will grow even higher this year as its combination hep C treatment, Harvoni,

AbbVie: New firm, new thinking

AbbVie: New firm, new thinking Gilead Sciences has emerged as the leader in this field with Sovaldi (sofosbuvir) and Harvoni (sofosbuvir/ledipasvir), both of which have already made billions of dollars.

The end of hepatitis C?

The end of hepatitis C? The launch of drugs such as Gilead's Sovaldi (sofosbuvir) and Harvoni (sofosbuvir and ledipasvir), AbbVie's Viekirax (ombitasvir/paritaprevir/ritonavir) and Exviera (dasabuvir), J&J's Olysio (simeprevir) and

Hepatitis C drugs drive US drug costs up in 2014

Hepatitis C drugs drive US drug costs up in 2014 exclusive formulary position for AbbVie's HCV therapy Viekira Pak (ombitasvir/paritaprevir/dasabuvir/ritonavir) - at the expense of Gilead's Sovaldi (sofosbuvir) and Harvoni (sofosbuvir/ledipasvir) - in return for a discounted

Gilead's Harvoni gains NICE yes - but won't face funding delay

Gilead's Harvoni gains NICE yes - but won't face funding delay The marketing authorisation for Harvoni specifically recommends treatment for genotypes 1, 3 (in combination with ribavirin) and 4. ... NICE says that as Harvoni can effectively cure the disease, this wipes out the cost of liver transplants, helping make

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics